See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The daughter of an American woman who is missing after she went ...

Security by default – protecting the enterprise in SQL Server 2025. Explore how SQL Server 2025 strengthens enterprise security through enforced secure defaults, identity integration, encryption and ...

An SQL injection vulnerability in Ally, a WordPress plugin from Elementor for web accessibility and usability with more than 400,000 installations, could be exploited to steal sensitive data without ...

Let’s say you spend three years and millions of dollars developing a revolutionary product. Your engineers have built the most elegant fintech API on the market. Perhaps your scientists have ...

President Donald Trump transmitted his State of the Union address in a call home to his planet of Earth II. That planet will soon be renamed Planet Trump in honor of its primary resident and king. We ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Shared decision-making—balancing clinical data with the patient's personal, logistical, and risk-tolerance factors—is essential for managing a chronic condition like follicular lymphoma. The shift ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

In Star Trek, it took until the year 2151 for a functional universal translator to come into existence, but Google is leveraging Gemini to accelerate that timeline. The company is offering real-time ...

Google will soon use Gemini 3 for more complex queries within Google Search. Jonathon Heard, Google’s industry head for insurance, told this to an audience at Simply Business’s London headquarters ...

Kiniksa Pharmaceuticals leverages ARCALYST as it is a first-in-class FDA-approved treatment for recurrent pericarditis, driving recurring revenue and strong growth. Q3 FY2025 ARCALYST revenue was $180 ...